← Leaderboards
Soman N Abraham
Duke University
$19,189,659
Attributed
$20,531,509
Total exposure
17
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$20,531,509 · 17
By mechanism
R01$14,888,796 · 8
R37$2,689,905 · 1
R21$2,083,903 · 5
R56$868,905 · 3
Top collaborators
- Kam W Leong5 shared
- Herman F. Staats4 shared
Most similar at Duke University
Same institution · by research overlap
- Herman F. Staats$31,192,841
- Karl B Thor$7,657,909
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsUrinary Tract InfectionInfectionMast CellMediatingResponseBladderImmune ResponseImmuneBacteriaUrineRecurrenceUropathogenic E. ColiBacterial InfectionsVaccinesAdjuvantEpithelial CellsEventMediator Of Activation ProteinPathogenEscherichia ColiImmunityPreventCombat
Grant awards (66)
Platelet- mast cell interactions as determinants of the vascular pathology in septic shock.$416,624
R01 · FY2024 · GM · contact PI
A novel vaccination strategy to curb recUTIs$201,250
R21 · FY2024 · AI · contact PI
Platelet- mast cell interactions as determinants of the vascular pathology in septic shock.$421,033
R01 · FY2023 · GM · contact PI
Loss of Bladder Control Following Recurrent Infections$379,141
R01 · FY2023 · DK · contact PI
A novel vaccination strategy to curb recUTIs$241,500
R21 · FY2023 · AI · contact PI
Platelet- mast cell interactions as determinants of the vascular pathology in septic shock.$418,121
R01 · FY2022 · GM · contact PI
Loss of Bladder Control Following Recurrent Infections$409,821
R01 · FY2022 · DK · contact PI
Aberrant remodeling of bladder following infection$401,650
R01 · FY2022 · DK · contact PI
Platelet- mast cell interactions as determinants of the vascular pathology in septic shock.$463,512
R01 · FY2021 · GM · contact PI
Loss of Bladder Control Following Recurrent Infections$415,612
R01 · FY2021 · DK · contact PI
Aberrant remodeling of bladder following infection$398,848
R01 · FY2021 · DK · contact PI
Loss of Bladder Control Following Recurrent Infections$426,212
R01 · FY2020 · DK · contact PI
Aberrant remodeling of bladder following infection$398,848
R01 · FY2020 · DK · contact PI
Combatting Bladder Cancer by Inducing Epithelial Turnover$168,894
R21 · FY2020 · CA · contact PI
Aberrant remodeling of bladder following infection$404,615
R01 · FY2019 · DK · contact PI
Immunotherapy to combat skin infections$278,905
R56 · FY2019 · AI · contact PI
Combatting Bladder Cancer by Inducing Epithelial Turnover$203,510
R21 · FY2019 · CA · contact PI
Immune mediated exocytosis of intravesicular UPEC from bladder cells$341,051
R01 · FY2017 · DK · contact PI
Mast Cells in Dengue Pathology and Prevention$387,199
R01 · FY2016 · HL · contact PI
Immune mediated exocytosis of intravesicular UPEC from bladder cells$341,051
R01 · FY2016 · DK · contact PI
Overcoming Immunosenescence by Nanoparticle-Mediated Activation$320,433
R01 · FY2016 · AI
Mast Cells in Dengue Pathology and Prevention$381,391
R01 · FY2015 · HL · contact PI
Immune mediated exocytosis of intravesicular UPEC from bladder cells$340,005
R01 · FY2015 · DK · contact PI
Overcoming Immunosenescence by Nanoparticle-Mediated Activation$334,818
R01 · FY2015 · AI
Overcoming Immunosenescence by Nanoparticle-Mediated Activation$392,500
R01 · FY2014 · AI
Mast Cells in Dengue Pathology and Prevention$379,455
R01 · FY2014 · HL · contact PI
Immune mediated exocytosis of intravesicular UPEC from bladder cells$336,863
R01 · FY2014 · DK · contact PI
Overcoming Immunosenescence by Nanoparticle-Mediated Activation$368,950
R01 · FY2013 · AI
Mast Cells in Dengue Pathology and Prevention$368,613
R01 · FY2013 · HL · contact PI
Overcoming Immunosenescence by Nanoparticle-Mediated Activation$392,500
R01 · FY2012 · AI
Mechanism of Bacterial Expulsion from Infected Bladder Cells.$200,000
R56 · FY2012 · DK · contact PI
Nasal adjuvant to enhance anti-cocaine vaccines$196,250
R21 · FY2012 · DA · contact PI
Modulation of Bladder cAMP to combat UTI's$302,293
R01 · FY2011 · DK · contact PI
Nasal adjuvant to enhance anti-cocaine vaccines$235,500
R21 · FY2011 · DA · contact PI
Caveolae Mediated Bacterial Uptake in the Urinary Tract$367,781
R01 · FY2010 · AI · contact PI
Modulation of Bladder cAMP to combat UTI's$305,346
R01 · FY2010 · DK · contact PI
Development of Efficacious Vaccine Against UTI's$99,999
R21 · FY2010 · DK · contact PI
Caveolae Mediated Bacterial Uptake in the Urinary Tract$371,495
R01 · FY2009 · AI · contact PI
Modulation of Bladder cAMP to combat UTI's$308,431
R01 · FY2009 · DK · contact PI
Development of Efficacious Vaccine Against UTI's$195,000
R21 · FY2009 · DK · contact PI
Modulation of Bladder cAMP to combat UTI's$103,522
R01 · FY2009 · DK · contact PI
Small cationic antimicrobial peptides: activators of innate & adaptive immunity$390,000
R56 · FY2008 · AI · contact PI
Caveolae Mediated Bacterial Uptake in the Urinary Tract$371,495
R01 · FY2008 · AI · contact PI
Modulation of Bladder cAMP to combat UTI's$308,431
R01 · FY2008 · DK · contact PI
LIGAND RECEPTOR INTERACTIONS IN UTIS$286,198
R37 · FY2008 · DK · contact PI
Development of Efficacious Vaccine Against UTI's$234,000
R21 · FY2008 · DK · contact PI
Caveolae Mediated Bacterial Uptake in the Urinary Tract$378,589
R01 · FY2007 · AI · contact PI
Modulation of Bladder cAMP to combat UTI's$328,726
R01 · FY2007 · DK · contact PI
LIGAND RECEPTOR INTERACTIONS IN UTIS$305,216
R37 · FY2007 · DK · contact PI
Caveolae Mediated Bacterial Uptake in the Urinary Tract$388,646
R01 · FY2006 · AI · contact PI
LIGAND RECEPTOR INTERACTIONS IN UTIS$300,762
R37 · FY2006 · DK · contact PI
LIGAND RECEPTOR INTERACTIONS IN UTIS$54,112
R37 · FY2006 · DK · contact PI
LIGAND RECEPTOR INTERACTIONS IN UTIS$13,105
R37 · FY2006 · DK · contact PI
Caveolae Mediated Bacterial Uptake by Mast Cells$346,500
R01 · FY2005 · AI
LIGAND RECEPTOR INTERACTIONS IN UTIS$308,000
R37 · FY2005 · DK
Proteome Mining in Caveolae of the Bladder Epithelium$154,000
R21 · FY2005 · AI
Caveolae Mediated Bacterial Uptake by Mast Cells$346,500
R01 · FY2004 · AI
LIGAND RECEPTOR INTERACTIONS IN UTIS$335,700
R37 · FY2004 · DK
Proteome Mining in Caveolae of the Bladder Epithelium$154,000
R21 · FY2004 · AI
Caveolae Mediated Bacterial Uptake by Mast Cells$346,500
R01 · FY2003 · AI
LIGAND RECEPTOR INTERACTIONS IN UTIS$283,867
R37 · FY2003 · DK
Caveolae Mediated Bacterial Uptake by Mast Cells$346,500
R01 · FY2002 · AI
LIGAND RECEPTOR INTERACTIONS IN UTIS$275,597
R37 · FY2002 · DK
Caveolae Mediated Bacterial Uptake by Mast Cells$329,175
R01 · FY2001 · AI
LIGAND RECEPTOR INTERACTIONS IN UTIS$267,570
R37 · FY2001 · DK
LIGAND RECEPTOR INTERACTIONS IN UTIS$259,778
R37 · FY2000 · DK